These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28954565)

  • 1. Endometrial Serous Carcinoma With Clear-Cell Change: Frequency and Immunohistochemical Analysis.
    Hariri N; Qarmali M; Fadare O
    Int J Surg Pathol; 2018 Apr; 26(2):126-134. PubMed ID: 28954565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of α-methylacyl-coenzyme-A racemase (p504s) immunohistochemistry in distinguishing endometrial clear cell carcinomas from serous and endometrioid carcinomas.
    Fadare O; Parkash V; Gwin K; Hanley KZ; Jarboe EA; Liang SX; Quick CM; Zheng W; Rawish KR; Hecht JL; Desouki MM
    Hum Pathol; 2013 Dec; 44(12):2814-21. PubMed ID: 24119561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical characterization of prototypical endometrial clear cell carcinoma--diagnostic utility of HNF-1β and oestrogen receptor.
    Hoang LN; Han G; McConechy M; Lau S; Chow C; Gilks CB; Huntsman DG; Köbel M; Lee CH
    Histopathology; 2014 Mar; 64(4):585-96. PubMed ID: 24103020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical Profiling of Endometrial Serous Carcinoma.
    Chen W; Husain A; Nelson GS; Rambau PF; Liu S; Lee CH; Lee S; Duggan MA; Köbel M
    Int J Gynecol Pathol; 2017 Mar; 36(2):128-139. PubMed ID: 27167671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic accuracy of HNF1β, Napsin A and P504S/Alpha-Methylacyl-CoA Racemase (AMACR) as markers of endometrial clear cell carcinoma.
    Travaglino A; Raffone A; Arciuolo D; Santoro A; Inzani F; Di Maio A; Visiello U; Fulgione C; Guida M; Mollo A; Insabato L; Zannoni GF
    Pathol Res Pract; 2022 Sep; 237():154019. PubMed ID: 35907281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Despite Diagnostic Morphology, Many Mixed Endometrial Carcinomas Show Unexpected Immunohistochemical Staining Patterns.
    Matrai CE; Pirog EC; Ellenson LH
    Int J Gynecol Pathol; 2018 Sep; 37(5):405-413. PubMed ID: 29019871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphologic and Immunohistochemical Study of Clear Cell Carcinoma of the Uterine Endometrium and Cervix in Comparison to Ovarian Clear Cell Carcinoma.
    Ju B; Wang J; Yang B; Sun L; Guo Y; Hao Q; Wu J
    Int J Gynecol Pathol; 2018 Jul; 37(4):388-396. PubMed ID: 28796747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Napsin A and WT 1 are useful immunohistochemical markers for differentiating clear cell carcinoma ovary from high-grade serous carcinoma.
    Rekhi B; Deodhar KK; Menon S; Maheshwari A; Bajpai J; Ghosh J; Shylasree ST; Gupta S
    APMIS; 2018 Jan; 126(1):45-55. PubMed ID: 29266433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Application of immunohistochemistry in differential diagnosis of endometrial carcinoma].
    Wu HW; Liu TH
    Zhonghua Bing Li Xue Za Zhi; 2012 Nov; 41(11):784-8. PubMed ID: 23302346
    [No Abstract]   [Full Text] [Related]  

  • 10. Frequent expression of napsin A in clear cell carcinoma of the endometrium: potential diagnostic utility.
    Fadare O; Desouki MM; Gwin K; Hanley KZ; Jarboe EA; Liang SX; Quick CM; Zheng W; Parkash V; Hecht JL
    Am J Surg Pathol; 2014 Feb; 38(2):189-96. PubMed ID: 24145649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical staining for Ki-67 and p53 helps distinguish endometrial Arias-Stella reaction from high-grade carcinoma, including clear cell carcinoma.
    Vang R; Barner R; Wheeler DT; Strauss BL
    Int J Gynecol Pathol; 2004 Jul; 23(3):223-33. PubMed ID: 15213598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted mutation analysis of endometrial clear cell carcinoma.
    Hoang LN; McConechy MK; Meng B; McIntyre JB; Ewanowich C; Gilks CB; Huntsman DG; Köbel M; Lee CH
    Histopathology; 2015 Apr; 66(5):664-74. PubMed ID: 25308272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunohistochemical profile of atypical eosinophilic syncytial changes vs serous carcinoma.
    Haley SL; Malhotra RK; Qiu S; Eltorky ME
    Ann Diagn Pathol; 2011 Dec; 15(6):402-6. PubMed ID: 21855381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Use of Napsin A and Glypican 3 to Distinguish Endometrial Clear Cell from Serous and Endometrioid Carcinomas.
    Miller EM; Tymon-Rosario J; Sunkara J; Harmon BE; Karabakhtsian RG; Novetsky AP
    Int J Gynecol Cancer; 2018 Sep; 28(7):1318-1324. PubMed ID: 30036224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic utility of hepatocyte nuclear factor 1-beta immunoreactivity in endometrial carcinomas: lack of specificity for endometrial clear cell carcinoma.
    Fadare O; Liang SX
    Appl Immunohistochem Mol Morphol; 2012 Dec; 20(6):580-7. PubMed ID: 22495362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The statuses of HER2 expression and mismatch repair in endometrial clear cell carcinoma.
    Bayramoglu Z; Erozbek SY; Ozdemir IA; Ulker V; Muezzinoglu B
    Pathol Res Pract; 2023 Jan; 241():154258. PubMed ID: 36516643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precursors of endometrial clear cell carcinoma.
    Fadare O; Liang SX; Ulukus EC; Chambers SK; Zheng W
    Am J Surg Pathol; 2006 Dec; 30(12):1519-30. PubMed ID: 17122507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic value of combined detection of HNF-1β and Napsin A in the diagnosis of ovarian clear cell carcinoma].
    Wang J; Li Q; Cheng X; Xiong K; Qi Q; Huang W
    Zhonghua Bing Li Xue Za Zhi; 2015 Dec; 44(12):874-8. PubMed ID: 26888504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ER+ /PR+ /TFF3+ /IMP3- immunoprofile distinguishes endometrioid from serous and clear cell carcinomas of the endometrium: a study of 401 cases.
    Mhawech-Fauceglia P; Yan L; Liu S; Pejovic T
    Histopathology; 2013 Jun; 62(7):976-85. PubMed ID: 23570281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct Histologic, Immunohistochemical and Clinical Features Associated With Serous Endometrial Intraepithelial Carcinoma Involving Polyps.
    Trinh VQ; Pelletier MP; Echelard P; Warkus T; Sauthier P; Gougeon F; Mès-Masson AM; Provencher DM; Rahimi K
    Int J Gynecol Pathol; 2020 Mar; 39(2):128-135. PubMed ID: 30789501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.